KORU Medical Systems Net Profit Margin 2010-2025 | KRMD
KORU Medical Systems net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| KORU Medical Systems Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.04B | $-0.01B | -17.14% |
| 2024-12-31 | $0.03B | $-0.01B | -21.21% |
| 2024-09-30 | $0.03B | $-0.01B | -38.71% |
| 2024-06-30 | $0.03B | $-0.01B | -36.67% |
| 2024-03-31 | $0.03B | $-0.01B | -41.38% |
| 2023-12-31 | $0.03B | $-0.01B | -42.86% |
| 2023-09-30 | $0.03B | $-0.01B | -25.00% |
| 2023-06-30 | $0.03B | $-0.01B | -24.14% |
| 2023-03-31 | $0.03B | $-0.01B | -27.59% |
| 2022-12-31 | $0.03B | $-0.01B | -32.14% |
| 2022-09-30 | $0.03B | $-0.01B | -29.63% |
| 2022-06-30 | $0.03B | $-0.01B | -32.00% |
| 2022-03-31 | $0.02B | $-0.01B | -25.00% |
| 2021-12-31 | $0.02B | $0.00B | -17.39% |
| 2021-09-30 | $0.02B | $0.00B | -19.05% |
| 2021-06-30 | $0.02B | $0.00B | -14.29% |
| 2021-03-31 | $0.02B | $0.00B | -13.04% |
| 2020-12-31 | $0.02B | $0.00B | -8.33% |
| 2020-09-30 | $0.03B | $0.00B | -3.85% |
| 2020-06-30 | $0.03B | 0 | 0.00% |
| 2020-03-31 | $0.02B | $0.00B | 4.17% |
| 2019-12-31 | $0.02B | $0.00B | 4.35% |
| 2019-09-30 | $0.02B | $0.00B | 4.76% |
| 2019-06-30 | $0.02B | 0 | 0.00% |
| 2019-03-31 | $0.02B | 0 | 0.00% |
| 2018-12-31 | $0.02B | 0 | 0.00% |
| 2018-09-30 | $0.02B | 0 | 0.00% |
| 2018-06-30 | $0.02B | 0 | 0.00% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-06-30 | $0.01B | 0 | 0.00% |
| 2017-03-31 | $0.01B | 0 | 0.00% |
| 2016-11-30 | $0.01B | 0 | 0.00% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | 0 | 0.00% |
| 2016-05-31 | $0.01B | 0 | 0.00% |
| 2015-08-31 | $0.01B | 0 | 0.00% |
| 2015-05-31 | $0.01B | 0 | 0.00% |
| 2014-08-31 | $0.01B | 0 | 0.00% |
| 2014-05-31 | $0.01B | 0 | 0.00% |
| 2013-08-31 | $0.01B | 0 | 0.00% |
| 2013-05-31 | $0.01B | 0 | 0.00% |
| 2012-05-31 | $0.00B | 0 | 0.00% |
| 2011-12-31 | $0.01B | 0 | 0.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.148B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.227B | 59.07 |
| Hims & Hers Health (HIMS) | United States | $12.367B | 128.49 |
| Tempus AI (TEM) | United States | $12.011B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.742B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.033B | 63.01 |
| Hinge Health (HNGE) | United States | $2.855B | 0.00 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Schrodinger (SDGR) | United States | $1.917B | 0.00 |
| Enovis (ENOV) | United States | $1.916B | 10.69 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.522B | 0.00 |
| Omnicell (OMCL) | United States | $1.463B | 25.82 |
| Azenta (AZTA) | United States | $1.393B | 64.72 |
| 10x Genomics (TXG) | United States | $1.311B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.663B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.645B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.33 |
| Outset Medical (OM) | United States | $0.366B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.288B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 3.60 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |